Literature DB >> 10193762

Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.

M G Scott1, C Swan, A P Wheatley, I P Hall.   

Abstract

By screening the 1470 bp 5' to the start codon of the human beta2 adrenergic receptor gene, we have identified a total of eight polymorphisms (-20 T-->C, -47 T-->C, -367 T-->C, -468 C-->G, -654 G-->A, -1023 G-->A, -1343 A-->G and -1429 T-->A c.f. beta2 adrenergic receptor start codon). Transient transfection of 5' flanking deletion luciferase reporter constructs demonstrated the majority of activity of the human beta2 adrenergic gene 5' flanking region to be present within a 549 bp fragment immediately upstream from the start codon. Because of linkage disequilibrium, some combinations of polymorphisms were particularly frequent. We transiently transfected COS-7 cells with luciferase constructs under the control of the 549 bp of 5' flanking DNA containing the two most frequent extended haplotypes in this region. Luciferase activity was significantly reduced in cells transfected with the 'mutant' construct (-20C, -47C, -367C, -468G) c.f. the 'wild-type' construct (-20T, -47T, -367T, -468C). These data suggest that polymorphisms have the potential to alter human beta2 adrenergic receptor gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193762      PMCID: PMC1571207          DOI: 10.1038/sj.bjp.0702385

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.

Authors:  S Tan; I P Hall; J Dewar; E Dow; B Lipworth
Journal:  Lancet       Date:  1997-10-04       Impact factor: 79.321

2.  Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization.

Authors:  L J Emorine; S Marullo; C Delavier-Klutchko; S V Kaveri; O Durieu-Trautmann; A D Strosberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Novel DNA sequence differences in the beta2-adrenergic receptor gene promoter region.

Authors:  B Timmermann; G H Li; F C Luft; P Lund-Johansen; F Skrabal; M R Hoehe
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions.

Authors:  B K Kobilka; T Frielle; H G Dohlman; M A Bolanowski; R A Dixon; P Keller; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

5.  The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis.

Authors:  A L Parola; B K Kobilka
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

6.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

Authors:  S A Green; J Turki; P Bejarano; I P Hall; S B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  1995-07       Impact factor: 6.914

7.  Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.

Authors:  J Turki; J Pak; S A Green; R J Martin; S B Liggett
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects.

Authors:  E Reihsaus; M Innis; N MacIntyre; S B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  1993-03       Impact factor: 6.914

9.  A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.

Authors:  S A Green; G Cole; M Jacinto; M Innis; S B Liggett
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

10.  Human lung cell beta 2-adrenergic receptors desensitize in response to in vivo administered beta-agonist.

Authors:  J Turki; S A Green; K B Newman; M A Meyers; S B Liggett
Journal:  Am J Physiol       Date:  1995-11
  10 in total
  25 in total

1.  Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects.

Authors:  A G Fenech; M J Ebejer; A E Felice; R Ellul-Micallef; I P Hall
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

3.  Beta 2 adrenergic receptor 5' haplotypes influence promoter activity.

Authors:  Sharon E Johnatty; Maha Abdellatif; Lawrence Shimmin; Richard B Clark; Eric Boerwinkle
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 4.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

5.  Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.

Authors:  Gregory A Hawkins; Kelan Tantisira; Deborah A Meyers; Elizabeth J Ampleford; Wendy C Moore; Barbara Klanderman; Stephen B Liggett; Stephen P Peters; Scott T Weiss; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

6.  Allele-specific binding of airway nuclear extracts to polymorphic beta2-adrenergic receptor 5' sequence.

Authors:  Alfredo Panebra; Mary Rose Schwarb; Clare B Glinka; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-25       Impact factor: 6.914

7.  Expression variation of the porcine ADRB2 has a complex genetic background.

Authors:  Eduard Murani; Siriluck Ponsuksili; Henry Reyer; Dörte Wittenburg; Klaus Wimmers
Journal:  Mol Genet Genomics       Date:  2013-08-31       Impact factor: 3.291

8.  Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells.

Authors:  B Lipworth; G H Koppelman; A P Wheatley; I Le Jeune; W Coutie; H Meurs; H F Kauffman; D S Postma; I P Hall
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

9.  Limited impact of multiple 5' single-nucleotide polymorphisms on the transcriptional control of the human beta 2-adrenoceptor gene.

Authors:  Robert Westland; Anneke van Veen; Henk M Jansen; Rene E Jonkers; Eddy A Wierenga
Journal:  Immunogenetics       Date:  2004-11-17       Impact factor: 2.846

10.  Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.

Authors:  Gabriele Nicolini; Nicola Scichilone; Andrea Bizzi; Alberto Papi; Leonardo M Fabbri
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.